Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment

N Palaskas, J Lopez‐Mattei, JB Durand… - Journal of the …, 2020 - Am Heart Assoc
Traditional cytotoxic chemotherapy and novel cancer therapies have various cardiotoxicities,
ranging from heart failure to arrhythmias. One of the most exciting developments in cancer …

Metal coordination complexes as therapeutic agents for ischemia-reperfusion injury

NP Bigham, JJ Wilson - Journal of the American Chemical Society, 2023 - ACS Publications
Ischemia-reperfusion injury (IRI), which describes the cell damage and death that occurs
after blood and oxygen are restored to ischemic or hypoxic tissue, is a significant factor …

Finerenone reduces risk of incident heart failure in patients with chronic kidney disease and type 2 diabetes: analyses from the FIGARO-DKD trial

G Filippatos, SD Anker, R Agarwal, LM Ruilope… - Circulation, 2022 - Am Heart Assoc
Background: Chronic kidney disease and type 2 diabetes are independently associated with
heart failure (HF), a leading cause of morbidity and mortality. In the FIDELIO-DKD …

Effect of a strategy of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization among patients with acute heart failure: the GALACTIC …

N Kozhuharov, A Goudev, D Flores, MT Maeder… - Jama, 2019 - jamanetwork.com
Importance Short-term infusions of single vasodilators, usually given in a fixed dose, have
not improved outcomes in patients with acute heart failure (AHF). Objective To evaluate the …

Psychometric testing of the revised self-care of heart failure index

B Riegel, C Barbaranelli, B Carlson… - Journal of …, 2019 - journals.lww.com
Background: Self-care is essential in people with chronic heart failure (HF). The process of
self-care was refined in the revised situation specific theory of HF self-care, so we updated …

[HTML][HTML] DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases

Y Handelsman, JE Anderson, GL Bakris… - Metabolism, 2024 - Elsevier
The spectrum of cardiorenal and metabolic diseases comprises many disorders, including
obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular …

[HTML][HTML] Chronic disease management in heart failure: focus on telemedicine and remote monitoring

P Alvarez, A Sianis, J Brown, A Ali… - Reviews in …, 2021 - imrpress.com
In the context of the COVID-19 pandemic, many barriers to telemedicine disappeared.
Virtual visits and telemonitoring strategies became routine. Evidence is accumulating …

Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial …

PS Pang, J Butler, SP Collins, G Cotter… - European heart …, 2017 - academic.oup.com
Aims Currently, no acute heart failure (AHF) therapy definitively improves outcomes.
Reducing morbidity and mortality from acute heart failure (AHF) remains an unmet need …

ACE2 and microbiota: emerging targets for cardiopulmonary disease therapy

CT Cole-Jeffrey, M Liu, MJ Katovich… - Journal of …, 2015 - journals.lww.com
The health of the cardiovascular and pulmonary systems is inextricably linked to the renin–
angiotensin system (RAS). Physiologically speaking, a balance between the …

Health status disparities by sex, race/ethnicity, and socioeconomic status in outpatients with heart failure

Y Khariton, ME Nassif, L Thomas, GC Fonarow, X Mi… - JACC: Heart Failure, 2018 - jacc.org
Objectives: This study sought to describe the health status of outpatients with heart failure
and reduced ejection fraction (HFrEF) by sex, race/ethnicity, and socioeconomic status …